Venous Ulcers
📧 Sign up to get email alerts when something new happens for Venous Ulcers.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study [NA]
This notice provides an update on the post-approval study of the GORE VIABAHN FORTEGRA Venous Stent, currently not recruiting.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Monitoring of Venous Ulcers Using a Bioimpedance Measurement Based Method and System [NA]
CutoSense Oy is recruiting for a study evaluating a bioimpedance-based monitoring system for venous ulcers.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Fetal Cell Receptors Repertoire [NA]
Clinical trial update for a study titled 'Fetal Cell Receptors Repertoire' sponsored by Assistance Publique - Hôpitaux de Paris, currently r…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: A Real-World Registry of Chronic Wounds and Ulcers
A real-world registry sponsored by U.S. Wound Registry is enrolling participants to collect data on chronic wounds and ulcers, including dia…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: The ROle of Compression StocKings in Heart Failure Patients [NA]
This clinical trial update indicates that the study titled 'The ROle of Compression StocKings in Heart Failure Patients' is currently recrui…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-04-09Clinical Trial Update: Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating a combination of topical growth factor and protease inhibitor for ch…
-
CLINICAL_TRIALS research · 2010-02-05Clinical Trial Update: Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers [Phase 1, Phase 2]
Phase I/II dose-ranging clinical trial evaluating CHRONSEAL for chronic venous leg ulcers, sponsored by Kringle Pharma Europe AB; status is …